News Focus
News Focus
Followers 46
Posts 6146
Boards Moderated 0
Alias Born 11/15/2013

Re: Hosai post# 471876

Monday, 10/21/2024 10:56:21 AM

Monday, October 21, 2024 10:56:21 AM

Post# of 515574
7:30 a.m. POSTER WALKING TOUR
9:00 a.m. LB9 - Phase IIb/III Trial of Blarcamesine in Early Alzheimer Disease Demonstrates Pre-specified Clinical Efficacy Through Upstream SIGMAR1 Activation

Marwan Sabbagh
, Juan-Carlos Lopez-Talavera
, Kun Jin
, William Chezem
, Christopher Missling
Barrow Neurological Institute - Phoenix (United States),
Anavex - New York (United State
Page 15
https://www.ctad-alzheimer.com/files/files/PROGRAM_CTAD2024_WEB%20OCTOBER%2018.pdf
Thanks for the link Hosai

Freedom is not free.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News